First COVID-19 ICU patients ventilated with Evone show remarkably rapid improvement
First COVID-19 ICU patients ventilated with Evone, a ventilator co-developed by Comate and Unitron, show remarkably rapid improvement
Two years ago, Ventinova Medical, Unitron and Comate Engineering & Design co-developed Evone, a ventilator with full respiratory control and higher efficient ventilation with lung protective potential. The innovative ventilator is currently undergoing a fast scale-up and is being used in the battle against COVID-19.
A number of COVID-19 patients with severe ARDS have received, or are still receiving ventilation with Evone. The first results show a clear increase on the Horowitz index – an important measure for respiratory status of a patient. Already in the 24-30 hours of FCV ventilation, an improvement ranging from 60% to 150% was observed. Although these results are preliminary and require further validation, they are perfectly in line with already described effects of FCV in ARDS.
Wouter Foulon, Founder of Comate: “It’s very important to us that we are doing everything we can to play our part in the fight against COVID-19. Working together and sharing expertise is crucial during these challenging times.”
More news & insights
On October 3, 2023, industry experts came together at SMAFACC, the premier event on Industry 4.0.
To celebrate 'Dag van de Ondernemer' UNIZO and VLAIO organized the "Innovatiefnemers" podcast
Wouter Foulon, founder of Comate, shed lights on the challenges hindering the progress of Belgian hardware companies in this Trends article.